| Literature DB >> 35124869 |
Stefano Damiani1, Alberto Donadeo1, Nicola Bassetti1, Gonzalo Salazar-de-Pablo2,3, Cecilia Guiot1, Pierluigi Politi1, Paolo Fusar-Poli1,2,4.
Abstract
AIMS: Source monitoring (SM) is the metacognitive ability to determine the origin of one's experiences. SM is altered in primary psychiatric psychosis, although relationships between SM subtypes, other cognitive domains and symptoms are unclear. Our aims were to synthesize evidence comparing psychosis -with and without hallucinations- and healthy controls classifying SM subtypes by source discrimination (internal/external/reality monitoring) and stimulus modality (visual/auditory/imagined/performed).Entities:
Keywords: externalizing bias; meta-analysis; psychosis; schizophrenia spectrum; source monitoring
Mesh:
Year: 2022 PMID: 35124869 PMCID: PMC9313862 DOI: 10.1111/pcn.13338
Source DB: PubMed Journal: Psychiatry Clin Neurosci ISSN: 1323-1316 Impact factor: 12.145
Fig. 1Source monitoring subtypes and stimulus modalities. In the first phase of source monitoring tasks, a stimulus (eg. a written or recorded sentence) is presented and encoded by the subject (eg. sentence read in mind or aloud). In the recognition phase, the stimulus is presented again, and the subject has to discriminate whether its original source was internal/self (blue) or external/non‐self (red). Arrows directions (O = original source ➔ A = answered source) represent the four possible types of source discrimination errors. ESM: external source monitoring; ISM: internal source monitoring; RM: reality monitoring.
Fig. 2Study selection criteria and flowchart. (a) Population, Intervention, Comparison and Outcomes and Study (PICOS) tool; (b) Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) flow chart.
List of demographic variables and meta‐regressors
| N subjects | males % | Age | IQ scale | IQ | Education years | Clinical scales | CPZeq. | Illness duration | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author Year | Diag. | PSY (H) | HC | PSY‐H (%) | PSY | HC | PSY | HC | PSY | HC | PSY | HC | ONRT | ||||
| Achim 2011 | SCH‐s | 25 | 25 | 23.6 (3.4) | 23.4 (3.6) | Shipley | 108.4 (15.4) | 120.8 (7.7) | 12.7 (2.5) | 15.6 (1.9) | PANSS | 3.1 (1.8) | 0 | ||||
| Allen 2004 | SCH | 28 (15) | 15 | 53.6 | 89.3 | 86.7 | 33.7 (9.3) | 33.1 (10.4) | NART | 106.4 (7.8) | 112 (7.1) | SAPS/SANS | 10.4 (11.1) | 0 | |||
| Anselmetti 2007 | SCH | 45 | 54 | 46.7 | 42.6 | 33.5 (11.4) | 32.2 (12.5) | 12.5 (2.5 | 13.6 (3.7) | PANSS |
8.8 (7.9) | 0/1 | |||||
| Arguedas 2012 | SCH‐s | 26 | 27 | 100 | 53.8 | 58.3 | 43.3 (10.1) | 46.0 (11.7) | WTAR | 101.5 (10.0) | 111.9 (8.4) | 12 (2.8) | 14.2 (2.6) | SAPS/SANS | 19.6 (10.2) | 0 | |
| Bendall 2011 | FEP | 43 (20) | 26 | 46.5 | 52.7 | 38.0 | 21.0 (3.4) | 21.2 (2.4) | NART | 106.4 (6.7) | 109.4 (3.6) | PANSS | 0 | ||||
| Bentall 1991 | SCH‐s | 38 (22) | 22 | 55.0 | 72.5 | 45.4 | 39.1 (10.7) | 35.4 (10.8) | clinical judgment | 1 | |||||||
| Brebion 1998 | SCH | 40 | 40 | 70.0 | 65.0 | 34.1 (11.1) | 37.1 (9.9) | 12.1 (2.4) | 13.2 (1.9) | 339 (346) | 11.7 (10.2) | 0 | |||||
| Brebion 2008 | SCH | 41 (17) | 41.5 | SAPS/SANS | 1 | ||||||||||||
| Brunelin 2006 | SCH | 61 (30) | 49.2 | 60.0 | 80.0 | 33.3 (8.4) | 10.8 (2.7) | PANSS | 509 (221) |
7.9 (9.3) | 1 | ||||||
| Brunelin 2007 | SCH | 15 | 15 | 28.6 (7.5) | 29.1 (7.3) | Raven PM | 11.1 (2.4) | 12.5 (1.8) | PANSS | 629 (692) | 0 | ||||||
| de Sousa 2016 | SCH‐s | 80 | 30 | 72.5 | 70.0 | 39.3 (11.6) | 38.4 (13.3) | Quick Test | 98.4 (10.6) | 109.5 (8.3) | 11.2 (1.9) | 12.7 (2.3) | PANSS | 469 (389) | 15.2 (10.9) | 0 | |
| Dondé 2019 | SCH | 29 | 29 | 72.4 | 79.3 | 37.3 (11.4) | 34.4 (12.6) | 10.9 (3.3) | 15.7 (3.6) | PANSS | 1113 (997) |
14.0 (9.4) | 1 | ||||
| Drakeford 2006 | SCH | 16 | 14 | 71 | 31 |
41.9 (11.5) |
38.1 (15.1) | NART |
106.3 (7.7) |
114.9 (7.6) | BPRS |
12.7 (7.3) | 1 | ||||
| Fairfield 2016 | SCH | 24 | 24 | 42.4 (6.8) | 40.6 (6.7) | WAIS‐R | 10.5 (3.4) | 11.1 (2.8) | BPRS | 380 | 0 | ||||||
| Fisher 2008 | SCH | 91 | 30 | 75.0 | 67.0 | 39.9 (11.4) | 39.7 (13.9) | WAIS‐R | 96 (12) | 108 (12) | 13 (2) | 15 (2) | 0/1 | ||||
| Franck 2000 | SCH | 17 (7) | 17 | 47.1 | 82.4 | 88.2 | 29.8 | 28.4 (5.2) | Raven PM | 9.5 (2.4) | 13.8 (3.7) | BPRS | 473 (371) |
8.8 (8.1) | 0/1 | ||
| Gaweda 2013 | SCH‐s | 54 (28) | 34 | 51.9 | 72.2 | 52.9 | 35.2 (10.4) | 33.2 (11.3) | 11.6 (1.0) | 11.9 (1.3) | PANSS |
10.9 (8.6) | 0/1 | ||||
| Gaweda 2018 | SCH‐s | 25 | 33 | 88.0 | 60.0 | 50.0 | 20.4 (2.2) | 20.3 (2.1) | 12.0 (0.2) | 11.8 (0.4) | BPRS | 406 (175) | 0/1 | ||||
| Harvey 1985 | SCH | 20 | 10 | 30.0 | 30.0 | 32.6 (8.4) | 30.9 (1.5) | CAPPS | 3.5 (1.1) | 3.6 (0.8) | 12.7 | 12.8 | 0/1 | ||||
| Harvey 1988 | SCH | 26 | 25 | 54.0 | 44.0 | 32.2 (8.1) | 30.6 (10.2) | 11.8 (2.2) | 13.1 (1.3) | SAPS/SANS | 710 (270) | 0 | |||||
| Henquet 2005 | SCH | 15 | 15 | 93.3 | 73.3 | 26.7 (6.4) | 26.6 (8.4) | GIT | 96.1 (10.2) | 113.5 (13.2) | PANSS | 0 | |||||
| Hommes 2012 | SCH‐s | 42 | 49 | 67.0 | 32.7 | 33.5 | 34.8 | WAIS‐III | 95.6 | 114.2 | PANSS | 0 | |||||
| Ilankovic 2011 | SCH | 23 | 23 | 100 | 47.8 | 47.8 | 33.3 (9.3) | 33.8 (9.3) | Wort‐schatz | 104.9 (13.3) | 110.6 (12.0) | 11.9 (2.4) | 12.5 (2.5) | SAPS/SANS |
4.7 (5.1) | 0 | |
| Johns 2006 | SCH‐s | 45 (15) | 20 | 33.3 | 78.0 | 60.0 | 34.9 | 33.7 | NART | 104 | 110 | SAPS/SANS | 9.1 | 0 | |||
| Johns 2001 | SCH‐s | 18 (10) | 20 | 55.6 | 83.0 | 80.0 | 39.1 | 36.7 | NART | 106.1 | 112.0 | 12.8 | 14.2 | case‐notes self‐reports |
16.8 (8.3) | 0 | |
| Lavallé 2020 | SCH | 38 | 29 | 52.6 | 31.0 | 41.0 (6.6) | 40.4 (9.3) | 12.2 (3.2) | 14.2 (2.9) | PANSS |
13.5 (7.8) | 0/1 | |||||
| Mammarella 2010 | SCH‐s | 26 | 26 | 84.6 | 53.8 | 39.2 (8.5) | 39.2 (8.6) | BIT | 102.2 (7.5) | 115.3 (2.8) | 9.1 (2.5) | 14.5 (2.5) | BPRS | 384 (158) |
15.4 (6.3) | 0 | |
| Moritz 2003 | SCH | 30 | 21 | 70.0 | 52.4 |
31.1 (8.3) |
27.0 (10.7) | MWT |
112.7 (12.8) |
112.9 (14.0) |
12.0 (1.8) |
11.53 (1.7) | BPRS |
253 (190) |
4.48 (6) | 0/1 | |
| Moritz 2005 | SCH | 30 | 15 | 63.3 | 53.3 |
37.3 (10.2) |
37.7 (12.5) | NART |
102.0 (9.4) |
110.6 (6.8) | SSPI |
672 (494) |
12.7 (7.3) | 0/1 | |||
| Moritz 2006 | SCH | 31 | 61 | 45.0 | 71.0 | 50.8 | 33.8 (9.9) | 31.1 (8.8) | 11.6 (1.7) | 12.0 (1.5) | PANSS | 687 (864) | 0 | ||||
| Morrison 1997 | SCH‐s | 30 (15) | 15 | 100 | 79.0 | 73.3 | 44.1 (13.0) | 39.6 (17.1) | NART | 101.9 (14.5) | 107.7 (13.6) | KGV‐R |
14.8 (9.6) | 0 | |||
| Nelson 2020 | FEP | 39 | 34 | 46.0 | 29.0 | 19.9 (3.2) | 21.1 (1.8) | WASI | 111.5 (15.9) | 107.5 (9.1) | BPRS CAARMS SANS | 0/1 | |||||
| Nienow 2004 | SCH | 52 | 52 | 55.8 | 48.1 | 36.2 (8.4) | 37.5 (7.2) | WAIS‐R | 87.8 (12.2) | 105.6 (8.4) | 12.4 (1.7) | 14.6 (1.7) | SAPS/SANS | 1 | |||
| Ragland 2006 | SCH | 16 | 15 | 87.5 | 86.6 | 34.8 (7.7) | 32.2 (7.0) | 13.2 (2.6) | 13.9 (1.9) | SAPS/SANS | 250 | 14.2 (9) | 0/1 | ||||
| Serrone 2019 | PSY | 37 (24) | 40 | 100 | 59.4 | 47.5 | 44 (11) | 40 (12) | PANSS | 18.5 (11.9) | 0 | ||||||
| Stephane 2010 | SCH‐s | 39 (31) | 26 | 79.5 | 92.0 | 96.1 | 52.6 (9.7) | 53.3 (10.2) | NART | 102.2 (8.8) | 106 (8.0) | 14 (3.3) | 14.5 (2.5) | BPRS SAPS/SANS | 309 (171) | 24.3 (12.8) | 0/1 |
| Szczepanowski 2020 | SCH | 39 | 50 | 64.1 | 26.0 | 38.4 (14.1) | 29.2 (8.1) | SAPS/SANS | 826 (1176) | 15.6 (10.5) | 0 | ||||||
| Szoke 2009 | SCH | 54 | 37 | 72.2 | 48.7 | 33.8 (9.5) | 45.6 (12.6) | SSPI | 0 | ||||||||
| Versmissen 2007 | PSY | 41 | 52 | 100 | 76.0 | 36.5 | 32.3 (10.4) | 47.0 (7.6) | GIT | 111.3 (20.6) | 124.5 (17.0 | 4.6 (1.2) | 5.6 (0.8) | PSE | 0 | ||
| Vinogradov 1997 | SCH | 26 | 21 | 100 | 54.0 | 43.0 | 40.2 (9.6) | 38.5 (7.6) | Shipley | 98.9 (12.8) | 111.1 (5.9) | 13.9 (1.7) | 14.9 (1.4) | BPRS | 360 | 1 | |
| Waters 2004 | SCH | 43 | 24 | 58.5 | 81.4 | 83.3 | 36.7 (8.4) | 34.7 (8.8) | NART | 100.2 (9.3) | 103.6 (4.8) | 11 (2) | 11.8 (1.9) | PANSS | 942 (445) |
13.6 (8.1) | 1 |
| Waters 2009 | SCH‐s | 41 | 20 | 44.2 | 35.6 (9.6) | 42.0 (10.4) | NART | 96.7 (11.0) | 100.2 (6.4) | 11.0 (1.6) | 11.3 (1.3) | SAPS/SANS | 642 (439) |
13 (8.8) | 1 | ||
| Werner 2014 | SCH | 20 | 18 | 75.0 | 72.2 | 37.1 (7.8) | 36.7 (8.9) | BACS | 256.8 (40.8) | 285.3 (23.3) | SAPS/SANS | 321 (334) | 0 | ||||
| Woodward 2007 | SCH‐s | 51 | 20 | 31.4 | 73.0 | 45.0 | 37.2 (9.4) | 40.0 (11.4) | 98.2 (8.6) | 110.2 (8.8) | SSPI | 663 (546) |
16.2 (8.4) | 0 | |||
Results are always reported as means (standard deviation).
Groups: H, patients with hallucinations; HC, healthy control; FEP, First Episode Psychosis; PSY, patients with psychosis (diagnosis of either schizophrenia spectrum or bipolar disorder with psychotic features); SCH, schizophrenia; SCH‐s, schizophrenia spectrum.
Headlines: Diag., Diagnosis; CPZ, eq antipsychotic dosages (chlorpromazine equivalents); IQ, intelligence quotient; ONRT, Old new recognition task (0 = no, 1 = yes, 0/1=).
Questionnaires: BACS, Brief Assessment of Cognition in Schizophrenia; BIT, Brief Intelligence Test; BPRS, Brief Psychiatric Rating Scale; CAPPS, Current and Past Psychopathology Scales; CAARMS, Comprehensive Assessment of At Risk Mental States; GIT, Groninger Intelligence Test; KGV‐R, Krawiecka, Goldberg, Vaughan psychosis scale; MWT, multiple choice vocabulary text; NART, National Adult Reading Test; PANSS, Positive and Negative Syndrome Scale; PSE, Present State Examination; Raven PM, Raven's Progressive Matrices; SANS, Scale for the Assessment of Negative Symptoms; SAPS, Scale for the Assessment of Positive Symptoms; SSPI, Signs and Symptoms of Psychotic Illness Rating Scale; WAIS, Wechsler Adult Intelligence Scale; WASI, Wechsler Abbreviated Scale Intelligence; WTAR, Wechsler Test of Adult Reading.
Meta‐analysis of source monitoring performance divided by source discrimination type
| No. of | SMD (r = 0.5) | Test for Heterogeneity | Egger's test | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Source Disc. | Studies | N PSY | N HC | Mean | 95% CI | z value | p‐value | Q | I2 |
| t value |
| |
|
| |||||||||||||
|
| |||||||||||||
| ESM | 12 | 438 | 355 | 0.398 | 0.226 | 0.570 | 4.263 | <0.001 | 22.755 | 51.660 | 0.019 | 0.698 | 0.519 |
| ISM | 12 | 419 | 353 | 0.513 | 0.315 | 0.711 | 5.079 | <0.001 | 25.689 | 57.180 | 0.007 | 0.375 | 0.716 |
| RMe | 24 | 906 | 672 | 0.407 | 0.307 | 0.507 | 7.274 | <0.001 | 23.014 | 0.061 | 0.460 | 0.478 | 0.641 |
| RMi | 26 | 946 | 758 | 0.374 | 0.270 | 0.477 | 6.611 | <0.001 | 28.624 | 12.661 | 0.280 | 1.279 | 0.142 |
|
| |||||||||||||
| ESM | 23 | 705 | 631 | 0.454 | 0.343 | 0.566 | 7.608 | <0.001 | 28.191 | 21.961 | 0.169 | 0.577 | 0.540 |
| ISM | 20 | 673 | 545 | 0.733 | 0.623 | 0.844 | 12.504 | <0.001 | 18.407 | <0.001 | 0.495 | 0.186 | 0.801 |
| ALL | 42 | 1566 | 1175 | 0.458 | 0.401 | 0.514 | 15.789 | <0.001 | |||||
|
| |||||||||||||
|
| |||||||||||||
| ESM | 4 | 91 | 79 | 0.083 | −0.188 | 0.353 | 0.600 | 0.548 | 0.183 | <0.001 | 0.980 | 1.272 | 0.331 |
| ISM | 3 | 65 | 62 | 0.291 | −0.040 | 0.621 | 1.725 | 0.085 | 1.804 | <0.001 | 0.406 | 24.253 | 0.026 |
| RMe | 10 | 186 | 180 | 0.410 | 0.173 | 0.647 | 3.387 | 0.001 | 11.893 | 24.326 | 0.219 | 3.075 | 0.015 |
| RMi | 7 | 149 | 144 | 0.169 | −0.053 | 0.390 | 1.493 | 0.135 | 2.909 | <0.001 | 0.820 | 0.260 | 0.806 |
|
| |||||||||||||
| ESM | 5 | 119 | 99 | 0.235 | −0.007 | 0.477 | 1.902 | 0.057 | 1.012 | <0.001 | 0.908 | 0.232 | 0.832 |
| ISM | 4 | 89 | 68 | 0.267 | −0.040 | 0.573 | 1.706 | 0.088 | 1.860 | <0.001 | 0.602 | 1.838 | 0.207 |
ESM, External Source Monitoring; HC, Healthy Controls; ISM, Internal Source Monitoring; PSY, Patients with psychosis; PSY‐H, Patients with Hallucinations; PSY‐NH, Patients without Hallucinations. RMe, Reality Monitoring externalizing bias; RMi, Reality Monitoring internalizing bias.
SMD (Standardized Mean Differences) are computed assuming a within‐study source monitoring measures correlation of 0.5.
No trim‐and‐fill modifications.
Trim‐and‐fill modification to SMD = 0.368; 95%CI = 0.105–0.631; Q Value: 16.371.
Meta‐analysis of source monitoring performance divided by stimulus modality
| No. of | SMD (r = 0.5) | Test for Heterogeneity | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stimulus Modality | Studies | N PSY | N HC | Mean | 95% CI | z value |
| Q | I2 |
| |
|
| |||||||||||
| Auditory | 14 | 459 | 439 | 0.420 | 0.286 | 0.553 | 6.156 | <0.001 | 13.409 | 3.052 | 0.417 |
| Visual | 18 | 655 | 593 | 0.372 | 0.271 | 0.474 | 7.195 | <0.001 | 16.543 | 0.000 | 0.486 |
| Imagined | 11 | 393 | 326 | 0.688 | 0.490 | 0.885 | 6.829 | <0.001 | 17.040 | 41.314 | 0.073 |
| Performed | 24 | 918 | 647 | 0.383 | 0.275 | 0.490 | 6.992 | <0.001 | 27.002 | 14.822 | 0.256 |
|
| |||||||||||
| Auditory | 13 | 402 | 323 | 0.676 | 0.475 | 0.876 | 6.611 | <0.001 | 21.183 | 43.351 | 0.048 |
| Visual | 16 | 593 | 485 | 0.358 | 0.190 | 0.527 | 4.172 | <0.001 | 32.332 | 53.606 | 0.006 |
| Imagined | 7 | 209 | 178 | 0.978 | 0.688 | 1.268 | 6.613 | <0.001 | 11.872 | 49.463 | 0.065 |
| Performed | 16 | 560 | 423 | 0.578 | 0.407 | 0.748 | 6.639 | <0.001 | 24.657 | 39.166 | 0.055 |
|
| |||||||||||
| Auditory | 7 | 131 | 126 | 0.277 | 0.031 | 0.523 | 2.203 | 0.028 | 6.585 | 8.888 | 0.976 |
| Visual | 3 | 69 | 63 | 0.042 | −0.252 | 0.336 | 0.278 | 0.781 | 0.231 | <0.001 | 0.891 |
| Imagined | 3 | 65 | 62 | 0.489 | 0.155 | 0.823 | 2.868 | 0.004 | 1.622 | <0.001 | 0.444 |
| Performed | 6 | 124 | 106 | 0.202 | −0.042 | 0.446 | 1.622 | 0.105 | 4.156 | <0.001 | 0.527 |
|
| |||||||||||
| Auditory | 3 | 61 | 42 | 0.209 | −0.169 | 0.587 | 1.081 | 0.279 | 1.782 | <0.001 | 0.410 |
| Visual | 3 | 82 | 70 | 0.162 | −0.122 | 0.446 | 1.118 | 0.264 | 1.568 | <0.001 | 0.457 |
| Imagined | 1 | 28 | 26 | 0.359 | −0.179 | 0.897 | 1.307 | 0.191 | 0.000 | <0.001 | 1.000 |
| Performed | 4 | 89 | 68 | 0.202 | −0.145 | 0.549 | 1.142 | 0.253 | 3.486 | 13.947 | 0.323 |
HC, Healthy Controls; PSY, Patients with psychosis; PSY‐H, Patients with Hallucinations; PSY‐NH, Patients without Hallucinations.
SMD (Standardized Mean Differences) are computed assuming a within‐study source monitoring measures correlation of 0.5.